Long path to MYC inhibition approaches clinical trials
Nat Rev Cancer
.
2019 May;19(5):252.
doi: 10.1038/s41568-019-0141-9.
Author
M Teresa Villanueva
1
Affiliation
1
Senior Editor, Nature Reviews Drug Discovery, . nrc@nature.com.
PMID:
30967650
DOI:
10.1038/s41568-019-0141-9
No abstract available
Publication types
Comment
MeSH terms
Gene Expression Regulation, Neoplastic*
Humans
Proto-Oncogene Proteins c-myc / genetics*
Substances
Proto-Oncogene Proteins c-myc